CLINICAL_TRIALS
trial_result
· 2021-12-06
Clinical Trial Update: Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) [Phase 1]
Summary
Phase 1 trial updating safety and immunogenicity of MV-ZIKA-RSP vaccine (V187-001) for Zika virus infection.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Themis Bioscience GmbH | Conditions: Zika Virus Infection | Phase 1 | Status: COMPLETED | Results posted: 2021-12-06